Clinical trials of the bone-replacement biocomposite FlexiOss called “artificial bone” as part of the Regional Operational Programme of the Lubelskie Voivodeship for 2014-2020, Measure 1.2 Targeted research.
The project aims at conducting clinical trials of an internationally innovative bone substitute biomaterial called “artificial bone” and initiating research on a new material functionally complementary to the biocomposite.
Conducting clinical trials of the FlexiOss® bone replacement biocomposite will allow the product to be fully introduced into the commercial market, which will promote the widespread use of “artificial bone” in medicine.
The composite will achieve high surgical handiness and the possibility of adjusting it to the dimensions of the bone defect being filled, as well as minimising the risk of virus contamination thanks to the use of a bacterial polymer, thus improving patients’ quality of life.
4.893.467,00 PLN
2.635.359,60 PLN
